Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Arterial lesions in giant cell arteritis: A longitudinal study.

Kermani TA, Diab S, Sreih AG, Cuthbertson D, Borchin R, Carette S, Forbess L, Koening CL, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Spiera RF, Warrington KJ, Ytterberg SR, Langford CA, Merkel PA, Khalidi NA; Vasculitis Clinical Research Consortium.

Semin Arthritis Rheum. 2018 May 9. pii: S0049-0172(18)30094-5. doi: 10.1016/j.semarthrit.2018.05.002. [Epub ahead of print]

PMID:
29880442
2.

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.

Cornec D, Kabat BF, Mills JR, Cheu M, Hummel AM, Schroeder DR, Cascino MD, Brunetta P, Murray DL, Snyder MR, Fervenza F, Hoffman GS, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Barnidge DR, Specks U.

Rheumatology (Oxford). 2018 Apr 1;57(4):639-650. doi: 10.1093/rheumatology/kex484.

PMID:
29340623
3.

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8.

Ah Kioon MD, Tripodo C, Fernandez D, Kirou KA, Spiera RF, Crow MK, Gordon JK, Barrat FJ.

Sci Transl Med. 2018 Jan 10;10(423). pii: eaam8458. doi: 10.1126/scitranslmed.aam8458.

PMID:
29321259
4.

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.

Gordon JK, Martyanov V, Franks JM, Bernstein EJ, Szymonifka J, Magro C, Wildman HF, Wood TA, Whitfield ML, Spiera RF.

Arthritis Rheumatol. 2018 Feb;70(2):308-316. doi: 10.1002/art.40358. Epub 2017 Dec 29.

PMID:
29073351
5.

Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment.

Haddon DJ, Wand HE, Jarrell JA, Spiera RF, Utz PJ, Gordon JK, Chung LS.

J Rheumatol. 2017 May;44(5):631-638. doi: 10.3899/jrheum.160833. Epub 2017 Mar 15.

6.

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Clain JM, Hummel AM, Stone JH, Fervenza FC, Hoffman GS, Kallenberg CG, Langford CA, McCune WJ, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Ytterberg SR, Specks U; WGET and RAVE-ITN Research Groups.

Clin Exp Immunol. 2017 Apr;188(1):174-181. doi: 10.1111/cei.12925. Epub 2017 Feb 7.

7.

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 May;69(5):1054-1066. doi: 10.1002/art.40034. Epub 2017 Apr 6.

8.

Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.

Bernstein EJ, Gordon JK, Spiera RF, Huang WT, Horn EM, Mandl LA.

Rheumatology (Oxford). 2017 Jan;56(1):87-94. doi: 10.1093/rheumatology/kew365. Epub 2016 Oct 25.

PMID:
28028158
9.

Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis.

Chia JJ, Zhu T, Chyou S, Dasoveanu DC, Carballo C, Tian S, Magro CM, Rodeo S, Spiera RF, Ruddle NH, McGraw TE, Browning JL, Lafyatis R, Gordon JK, Lu TT.

J Clin Invest. 2016 Nov 1;126(11):4331-4345. doi: 10.1172/JCI85740. Epub 2016 Oct 10.

11.

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Cartin-Ceba R, Indrakanti D, Specks U, Stone JH, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Spiera RF, Monach PA, St Clair EW, Seo P, Tchao NK, Ytterberg SR, Brunetta PG, Song H, Birmingham D, Rovin BH; RAVE-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2017 Jan;69(1):169-175. doi: 10.1002/art.39822.

12.

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.

Mills JR, Cornec D, Dasari S, Ladwig PM, Hummel AM, Cheu M, Murray DL, Willrich MA, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U, Barnidge DR.

Anal Chem. 2016 Jun 21;88(12):6317-25. doi: 10.1021/acs.analchem.6b00544. Epub 2016 Jun 3.

13.

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.

Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin-Ceba R, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, William St Clair E, Tchao NK, Stone JH, Specks U; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2016 Jul;68(7):1700-10. doi: 10.1002/art.39637.

14.

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.

Johnson ME, Grassetti AV, Taroni JN, Lyons SM, Schweppe D, Gordon JK, Spiera RF, Lafyatis R, Anderson PJ, Gerber SA, Whitfield ML.

Arthritis Res Ther. 2016 Jan 22;18:27. doi: 10.1186/s13075-016-0914-4.

15.

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial.

Gordon JK, Martyanov V, Magro C, Wildman HF, Wood TA, Huang WT, Crow MK, Whitfield ML, Spiera RF.

Arthritis Res Ther. 2015 Aug 18;17:213. doi: 10.1186/s13075-015-0721-3.

16.

A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis.

Rice LM, Ziemek J, Stratton EA, McLaughlin SR, Padilla CM, Mathes AL, Christmann RB, Stifano G, Browning JL, Whitfield ML, Spiera RF, Gordon JK, Simms RW, Zhang Y, Lafyatis R.

Arthritis Rheumatol. 2015 Nov;67(11):3004-15. doi: 10.1002/art.39287.

17.

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML, Spiera RF, Christmann RB, Gordon JK, Weinberg J, Simms RW, Lafyatis R.

J Clin Invest. 2015 Jul 1;125(7):2795-807. doi: 10.1172/JCI77958. Epub 2015 Jun 22.

18.

Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Grayson PC, Carmona-Rivera C, Xu L, Lim N, Gao Z, Asare AL, Specks U, Stone JH, Seo P, Spiera RF, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ytterberg SR, Phippard DJ, Merkel PA, Kaplan MJ, Monach PA; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2015 Jul;67(7):1922-32. doi: 10.1002/art.39153.

19.

Pulmonary vasculitis.

Lally L, Spiera RF.

Rheum Dis Clin North Am. 2015 May;41(2):315-31. doi: 10.1016/j.rdc.2015.01.004. Epub 2015 Feb 27. Review.

PMID:
25836645
20.

Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's).

Lally L, Lebovics RS, Huang WT, Spiera RF.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1403-9.

PMID:
25299002
21.

Imatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.

Gordon J, Udeh U, Doobay K, Magro C, Wildman H, Davids M, Mersten JN, Huang WT, Lyman S, Crow MK, Spiera RF.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-189-93. Epub 2014 Aug 15.

PMID:
25152211
22.

Practice patterns of ANCA-associated vasculitis: exploring differences among subspecialties at a single academic medical centre.

Forbess LJ, Griffin KW, Spiera RF.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S48-50. Epub 2014 May 16.

23.

Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Levine AB, Kalliolias G, Heaney M, Endo Y, Gersten A, Weinsaft JW, Spiera RF, Bass A, Erkan D.

HSS J. 2012 Oct;8(3):313-9. doi: 10.1007/s11420-012-9276-x. Epub 2012 Jun 23. No abstract available.

24.

Biomarkers in ANCA-associated vasculitis.

Lally L, Spiera RF.

Curr Rheumatol Rep. 2013 Oct;15(10):363. doi: 10.1007/s11926-013-0363-x. Review.

PMID:
23955064
25.

Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.

Bernstein EJ, Mandl LA, Gordon JK, Spiera RF, Horn EM.

Arthritis Care Res (Hoboken). 2013 Oct;65(10):1713-8. doi: 10.1002/acr.22051.

26.

Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.

Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, Carrington K, Zhang SS, Pulit SL, Ripke S, Carette S, Dellaripa PF, Edberg JC, Hoffman GS, Khalidi N, Langford CA, Mahr AD, St Clair EW, Seo P, Specks U, Spiera RF, Stone JH, Ytterberg SR, Raychaudhuri S, de Bakker PI, Farrer LA, Amos CI, Merkel PA, Siminovitch KA.

Arthritis Rheum. 2013 Sep;65(9):2457-68. doi: 10.1002/art.38036.

27.

Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort.

Forbess LJ, Gordon JK, Doobay K, Bosworth BP, Lyman S, Davids ML, Spiera RF.

Rheumatology (Oxford). 2013 May;52(5):939-43. doi: 10.1093/rheumatology/kes390. Epub 2013 Jan 18.

28.

Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis.

Chung SA, Xie G, Roshandel D, Sherva R, Edberg JC, Kravitz M, Dellaripa PF, Hoffman GS, Mahr AD, Seo P, Specks U, Spiera RF, St Clair EW, Stone JH, Plenge RM, Siminovitch KA, Merkel PA, Monach PA.

Arthritis Rheum. 2012 Oct;64(10):3463-71. doi: 10.1002/art.34496.

29.

Cyclophosphamide responsive interstitial lung disease in "overlap syndrome": a clinical pathology conference held by the division of rheumatology at the hospital for special surgery.

Schulman E, Chen K, Saboeiro G, Sanders A, Kirou K, Spiera RF, Bass AR, Erkan D.

HSS J. 2011 Feb;7(1):99-105. doi: 10.1007/s11420-010-9186-8. Epub 2010 Oct 26. No abstract available.

30.

IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.

Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC Jr, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg JC, Kimberly RP.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20736-41. doi: 10.1073/pnas.1109227109. Epub 2011 Dec 6.

31.

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).

Clowse ME, Copland SC, Hsieh TC, Chow SC, Hoffman GS, Merkel PA, Spiera RF, Davis JC Jr, McCune WJ, Ytterberg SR, St Clair EW, Allen NB, Specks U, Stone JH; WGET Research Group.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1777-81. doi: 10.1002/acr.20605.

32.

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial.

Spiera RF, Gordon JK, Mersten JN, Magro CM, Mehta M, Wildman HF, Kloiber S, Kirou KA, Lyman S, Crow MK.

Ann Rheum Dis. 2011 Jun;70(6):1003-9. doi: 10.1136/ard.2010.143974. Epub 2011 Mar 11.

33.

Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.

Mahr AD, Edberg JC, Stone JH, Hoffman GS, St Clair EW, Specks U, Dellaripa PF, Seo P, Spiera RF, Rouhani FN, Brantly ML, Merkel PA.

Arthritis Rheum. 2010 Dec;62(12):3760-7. doi: 10.1002/art.27742.

34.

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis.

Gordon JK, Spiera RF.

Curr Opin Rheumatol. 2010 Nov;22(6):690-5. doi: 10.1097/BOR.0b013e32833f1105. Review.

PMID:
20827202
35.

Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis.

Mahr AD, Neogi T, Lavalley MP, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St Clair EW, Stone JH, Merkel PA; Wegener's Granulomatosis Etanercept Trial Research Group.

Arthritis Rheum. 2008 Jun 15;59(6):884-91. doi: 10.1002/art.23707.

36.

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

Mahr AD, Jover JA, Spiera RF, Hernández-García C, Fernández-Gutiérrez B, Lavalley MP, Merkel PA.

Arthritis Rheum. 2007 Aug;56(8):2789-97.

37.

Ehrlichiosis as a near-fatal cause of postoperative fever after bilateral total knee arthroplasty.

Tarantino SJ, Thomas AJ, Spiera RF, Sculco TP.

J Knee Surg. 2006 Oct;19(4):273-5. No abstract available.

PMID:
17080650
38.

Therapy for giant cell arteritis: can we do better?

Spiera RF, Spiera H.

Arthritis Rheum. 2006 Oct;54(10):3071-4. No abstract available.

39.

A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.

Stone JH, Rajapakse VN, Hoffman GS, Specks U, Merkel PA, Spiera RF, Davis JC, St Clair EW, McCune J, Ross S, Hitt BA, Veenstra TD, Conrads TP, Liotta LA, Petricoin EF 3rd; Wegener's Granulomatosis Etanercept Trial Research Group.

Arthritis Rheum. 2005 Mar;52(3):902-10.

40.

Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.

Spiera RF, Kupersmith M, Paget S, Spiera H.

Arthritis Rheum. 2003 Apr;48(4):1159-60; author reply 1160-1. No abstract available.

41.

Ticlopidine-induced lupus: a report of 4 cases.

Spiera RF, Berman RS, Werner AJ, Spiera H.

Arch Intern Med. 2002 Oct 28;162(19):2240-3.

PMID:
12390069
42.

Long-term outcome in lupus nephritis.

Spiera RF, Homel P, Spiera H.

Ann Intern Med. 2002 Sep 17;137(6):545-6; author reply 545-6. No abstract available.

PMID:
12230360
43.

Methotrexate in giant-cell arteritis.

Spiera RF, Paget S, Spiera H.

Ann Intern Med. 2001 Dec 4;135(11):1006-7. No abstract available.

PMID:
11730407
44.

A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG, Paget SA.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495-501.

PMID:
11579707
45.

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA; International Network for the Study of the Systemic Vasculitides (INSSYS).

Arthritis Rheum. 2001 Apr;44(4):912-20.

46.

Silicone breast implants and connective tissue disease: an overview.

Spiera H, Spiera RF.

Mt Sinai J Med. 1997 Nov;64(6):363-71. Review.

PMID:
9364829
47.

Scleroderma in women with silicone breast implants: comment on the article by Sánchez-Guerrero et al.

Spiera RF, Gibofsky A, Spiera H.

Arthritis Rheum. 1995 May;38(5):719, 721. No abstract available.

PMID:
7748229
48.

Breast implants and connective-tissue diseases.

Spiera RF, Gibofsky A, Spiera H.

N Engl J Med. 1994 Nov 3;331(18):1232; author reply 1233-4. No abstract available.

PMID:
7935669
49.

Esophageal involvement in Wegener's granulomatosis.

Spiera RF, Filippa DA, Bains MS, Paget SA.

Arthritis Rheum. 1994 Sep;37(9):1404-7.

PMID:
7945506
50.

Silicone gel filled breast implants and connective tissue disease: an overview.

Spiera RF, Gibofsky A, Spiera H.

J Rheumatol. 1994 Feb;21(2):239-45. Review.

PMID:
8182631

Supplemental Content

Loading ...
Support Center